Literature DB >> 20219911

Different potential of C-type lectin-mediated entry between Marburg virus strains.

Keita Matsuno1, Noriko Kishida, Katsuaki Usami, Manabu Igarashi, Reiko Yoshida, Eri Nakayama, Masayuki Shimojima, Heinz Feldmann, Tatsuro Irimura, Yoshihiro Kawaoka, Ayato Takada.   

Abstract

The glycoproteins (GPs) of filoviruses are responsible for virus entry into cells. It is known that GP interacts with cellular C-type lectins for virus attachment to cells. Since primary target cells of filoviruses express C-type lectins, C-type lectin-mediated entry is thought to be a possible determinant of virus tropism and pathogenesis. We compared the efficiency of C-type lectin-mediated entry between Marburg virus strains Angola and Musoke by using a vesicular stomatitis virus (VSV) pseudotype system. VSV pseudotyped with Angola GP (VSV-Angola) infected K562 cells expressing the C-type lectin, human macrophage galactose-type C-type lectin (hMGL), or dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) more efficiently than VSV pseudotyped with Musoke GP (VSV-Musoke). Unexpectedly, the binding affinity of the C-type lectins to the carbohydrates on GPs did not correlate with the different efficiency of C-type lectin-mediated entry. Site-directed mutagenesis identified the amino acid at position 547, which switched the efficiency of C-type lectin-mediated entry. In a three-dimensional model of GP, this amino acid was in close proximity to the putative site of cathepsin processing. Interestingly, the cathepsin inhibitors reduced the infectivity of VSV-Angola less efficiently than that of VSV-Musoke in C-type lectin-expressing K562 cells, whereas only a limited difference was found in control cells. The amino acid at position 547 was critical for the different effects of the inhibitors on the virus infectivities. These results suggest that the efficiency of C-type lectin-mediated entry of filoviruses is controlled not only by binding affinity between C-type lectins and GP but also by mechanisms underlying endosomal entry, such as proteolytic processing by the cathepsins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219911      PMCID: PMC2863822          DOI: 10.1128/JVI.02021-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells.

Authors:  K J Davis; A O Anderson; T W Geisbert; K E Steele; J B Geisbert; P Vogel; B M Connolly; J W Huggins; P B Jahrling; N K Jaax
Journal:  Arch Pathol Lab Med       Date:  1997-08       Impact factor: 5.534

2.  Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.

Authors:  Z Y Yang; H J Duckers; N J Sullivan; A Sanchez; E G Nabel; G J Nabel
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

3.  Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor.

Authors:  Jens H Kuhn; Sheli R Radoshitzky; Alexander C Guth; Kelly L Warfield; Wenhui Li; Martin J Vincent; Jonathan S Towner; Stuart T Nichol; Sina Bavari; Hyeryun Choe; M Javad Aman; Michael Farzan
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

4.  A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry.

Authors:  Anthony C Wong; Rohini G Sandesara; Nirupama Mulherkar; Sean P Whelan; Kartik Chandran
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

5.  Association of Ebola-related Reston virus particles and antigen with tissue lesions of monkeys imported to the United States.

Authors:  T W Geisbert; P B Jahrling; M A Hanes; P M Zack
Journal:  J Comp Pathol       Date:  1992-02       Impact factor: 1.311

6.  Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain.

Authors:  W Weissenhorn; A Carfí; K H Lee; J J Skehel; D C Wiley
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

7.  Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.

Authors:  Kartik Chandran; Nancy J Sullivan; Ute Felbor; Sean P Whelan; James M Cunningham
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

8.  Protease-mediated entry via the endosome of human coronavirus 229E.

Authors:  Miyuki Kawase; Kazuya Shirato; Shutoku Matsuyama; Fumihiro Taguchi
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

9.  Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR.

Authors:  George Lin; Graham Simmons; Stefan Pöhlmann; Frédéric Baribaud; Houping Ni; George J Leslie; Beth S Haggarty; Paul Bates; Drew Weissman; James A Hoxie; Robert W Doms
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  25 in total

Review 1.  Filovirus entry into cells - new insights.

Authors:  Emily Happy Miller; Kartik Chandran
Journal:  Curr Opin Virol       Date:  2012-03-23       Impact factor: 7.090

2.  Marburg virus glycoprotein GP2: pH-dependent stability of the ectodomain α-helical bundle.

Authors:  Joseph S Harrison; Jayne F Koellhoffer; Kartik Chandran; Jonathan R Lai
Journal:  Biochemistry       Date:  2012-03-12       Impact factor: 3.162

3.  Antibody-dependent enhancement of Marburg virus infection.

Authors:  Eri Nakayama; Daisuke Tomabechi; Keita Matsuno; Noriko Kishida; Reiko Yoshida; Heinz Feldmann; Ayato Takada
Journal:  J Infect Dis       Date:  2011-11       Impact factor: 5.226

4.  C-type lectins do not act as functional receptors for filovirus entry into cells.

Authors:  Keita Matsuno; Eri Nakayama; Osamu Noyori; Andrea Marzi; Hideki Ebihara; Tatsuro Irimura; Heinz Feldmann; Ayato Takada
Journal:  Biochem Biophys Res Commun       Date:  2010-11-05       Impact factor: 3.575

5.  Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.

Authors:  Makoto Kuroda; Daisuke Fujikura; Asuka Nanbo; Andrea Marzi; Osamu Noyori; Masahiro Kajihara; Junki Maruyama; Keita Matsuno; Hiroko Miyamoto; Reiko Yoshida; Heinz Feldmann; Ayato Takada
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

6.  Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein.

Authors:  Masahiro Kajihara; Andrea Marzi; Eri Nakayama; Takeshi Noda; Makoto Kuroda; Rashid Manzoor; Keita Matsuno; Heinz Feldmann; Reiko Yoshida; Yoshihiro Kawaoka; Ayato Takada
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

7.  Novel mutations in Marburg virus glycoprotein associated with viral evasion from antibody mediated immune pressure.

Authors:  Masahiro Kajihara; Eri Nakayama; Andrea Marzi; Manabu Igarashi; Heinz Feldmann; Ayato Takada
Journal:  J Gen Virol       Date:  2013-01-03       Impact factor: 3.891

8.  Sequence variability in viral genome non-coding regions likely contribute to observed differences in viral replication amongst MARV strains.

Authors:  Jesus A Alonso; Jean L Patterson
Journal:  Virology       Date:  2013-03-16       Impact factor: 3.616

9.  Characterization of the envelope glycoprotein of a novel filovirus, lloviu virus.

Authors:  Junki Maruyama; Hiroko Miyamoto; Masahiro Kajihara; Hirohito Ogawa; Ken Maeda; Yoshihiro Sakoda; Reiko Yoshida; Ayato Takada
Journal:  J Virol       Date:  2013-10-16       Impact factor: 5.103

Review 10.  Serological assays based on recombinant viral proteins for the diagnosis of arenavirus hemorrhagic fevers.

Authors:  Shuetsu Fukushi; Hideki Tani; Tomoki Yoshikawa; Masayuki Saijo; Shigeru Morikawa
Journal:  Viruses       Date:  2012-10-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.